Compare Djasa Ubersakti Tbk. (PTDU) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Djasa Ubersakti Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Djasa Ubersakti Tbk. trades at Rp70 (market cap 103.5B, 856.3K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Djasa Ubersakti Tbk. and Organon Pharma Indonesia Tbk. are close in size by market cap. Which is the better fit depends on your goals.
| PTDU | SCPI | |
|---|---|---|
Market Cap | 103.5B | 104.4B |
Volume | 856.3K | — |
Lot | 8.56K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Djasa Ubersakti Tbk.
PT Djasa Ubersakti Tbk (the Company) was established dated February 22, 1971 based on Notarial Deed No. 09 dari Shella Falianti S.H. Notary in Jakarta. The Company started its commercialoperations in 1971.
Read more on PTDU →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
